Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ATTO · NASDAQ · Biological Products, (No Diagnostic Substances) · No 10-K yet
$15.10−0.48 (−3.08%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Attovia Therapeutics (ATTO) · oqro.io/stocks/ATTO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
venBio Global Strategic Fund IV, L.P. now owns 9.2% of ATTO as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
GOLDMAN SACHS GROUP INC now owns 6.7% of ATTO as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
Alamar HoldCo, LLC now owns 7.1% of ATTO as a passive investorSource